Prothena Corp Public LTD: Peers

The FY2023 (Dec) proxy of Prothena Corp Public LTD names 19 peer companies for pay. Among Prothena Corp Public LTD and these peers, CEO pay was 6th highest of 10 and total shareholder return was 3rd highest of 10.

6th highest of 10in Prothena Corp Public LTD and its pay peers, FY2023 (Dec) by CEO pay:

$3.6M$10.1M

3rd highest of 10in Prothena Corp Public LTD and its pay peers, FY2023 (Dec) by total shareholder return:

$29$1,778

Pay peer group, FY2023 (Dec) proxy

Arcus Biosciences
Cytokinetics
Celldex Therapeutics
Denali Therapeutics
Anaptysbio
Krystal Biotech
Kura Oncology
Iovance Biotherapeutics
Replimune Group
AlectorNot disclosedNot disclosed
Anavex Life SciencesNot disclosedNot disclosed
Arrowhead PharmaceuticalsNot disclosedNot disclosed
Crinetics PharmaceuticalsNot disclosedNot disclosed
ImmunoGenNot disclosedNot disclosed
Karuna TherapeuticsNot disclosedNot disclosed
Kodiak SciencesNot disclosedNot disclosed
Mersana TherapeuticsNot disclosedNot disclosed
NGM BiopharmaceuticalsNot disclosedNot disclosed
Sangamo TherapeuticsNot disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.